FDA Investigator Demario L Walls

Demario L Walls has conducted inspections on 29 sites in 3 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
29
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100001939
Countries of Inspections:
United States of America, Brazil, India
FDA Investigators that have inspected at least one site in common with Demario L Walls:
Abdollah Koolivand, Ademola O Daramola, Ann B Borromeo, Ann L Demarco, Anna E Fain, Benjamin E Bowen, Bonita S Chester, Brandon C Heitmeier, Brittny C Cargo, Camerson E Moore, CDR Thomas R Berry, PPh, Charles M Edwards, Cherie T Parker, Cheryl L Watson, Christopher B May, Christopher J Adams, Claire M Minden, Clifton L Randell, Clinton J Lott, Cody D Rickman, Constance Y Fears, Cynthia Jim, CSO, Cynthia L Bolte, Cynthia L Medlin, Danielle M Maddox, David E Lowe, David J Gomes, Dennis Cantellops Paite, Desiree D Clark, Deyaa Shaheen, Diane P Goyette, Edward Deberry, Edward H Maticka, Edwin Melendez, Eileen J Bannerman, Elizabeth D Connell, Elizabeth L Holmes, Emily E Smith, Erica M Katherine, Fabian Nchaparro Rodriguez, Farhana Khan, Frank Wackes, Frederic W French, III, Gabriel R Mclemore, George J Flynn, Goran Periz, PhD, Gretchen M Laws, Ibad U Khan, Ivy E Sweeney, Jamie L Port, Jared P Stevens, Jason F Chancey, Jawaid Hamid, Jeff M Uriarte, Jennifer L Huntington, Jessica L Pressley, Johann M Fitch, John A Gonzalez, John E Russell, Jr, Julius I Jones, June P Page, Karen C Daugherty, Kemejumaka N Opara, Kenneth R Merritt, Kerry Ann Latham, Kip J Hanks, Krista W Whitten, Larry K Hampton, Laura L Staples, Lauryl A Smith, Leah M Andrews, Lequita M Mayhew, Lesley K Satterwhite, Libia M Lugo, Linda M Athey, Louis G An, LT Tamara J Henderson, Marcus L Head, Margaret M Annes, Markeesa M Scales, Marvin D Jones, Mary Jeanet Mcgarry, Megan T Ziegler, Melanie L Drayton, Melanie M Walker, Meocha V Whaley, Michael S Budziak, Muralidhara B Gavini, PhD, Narong Chamkasem, PhD, Nicole A Lloyd, Nicole E Knowlton, Noreen Muñiz, Patty P Kaewussdangkul, Paul A Bonneau, Penny H Mccarver, Postelle Birch Smith, R Edwadebey Deberry, Rachael L Cook, Rebecca Rodriguez, Regan T Harp, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Safronia Jenkins, Samantha J Bradley, Sandy L Atkins, Santos E Camara, Saundrea A Munroe, Sayeeda Hdabe, Scott T Ballard, Seneca D Toms, Sha'tina R Alridge, Sharna D Pratt, Shondra N Gipson, Sina Shojaee, Song Y Lavalais, Sonya M Edmonds, Steven D Dittert, Steven M Weinman, Susan O Oladeji, Susan T Hadman, Thomas R Stanley, Torrance J Slayton, Tracy J Washington, Travis E Chapman, Unnee Ranjan, Veronica Fuentes, MS, Vincent Thomas, Viviana Matta, Walden H Lee, Wayne D Mcgrath, Xiomara Copeland, Zada L Giles

Demario L Walls's Documents

Publish Date Document Type Title
February, 2024 FDA 483 Baxter Healthcare Corporation - Form 483, 2024-02-09
June, 2023 FDA 483 Med Shop Total Care Inc. - Form 483, 2023-06-08
January, 2023 FDA 483 Cornerstone Laboratories, LLC - Form 483, 2023-01-19
March, 2024 FDA 483 KOBAYASHI America Manufacturing, LLC - Form 483, 2024-03-15
November, 2022 FDA 483 Consumer Product Partners, LLC - Form 483, 2022-11-07
September, 2022 FDA 483 Sircle Laboratories, L.L.C. - Form 483, 2022-09-16
June, 2022 FDA 483 L'OREAL USA, INC. - Form 483, 2022-06-24
August, 2021 FDA 483 Eagle Pharmacy, Inc. - Form 483, 2021-08-12
April, 2020 FDA 483 Medical Center Pharmacy, Inc. - Form 483, 2020-04-09
December, 2023 FDA 483 EMPOWER CLINIC SERVICES LLC - Form 483, 2023-12-01
January, 2024 FDA 483 Everzinc Corporation - Form 483, 2024-01-12
August, 2022 FDA 483 Polarean, Inc. - Form 483, 2022-08-19
May, 2022 FDA 483 S.s.s. Company (international) - Form 483, 2022-05-27
July, 2022 FDA 483 Response Nephron Sterile Compounding Center, LLC - Form 483R, 2022-04-20
September, 2023 FDA 483 Ionetix Corporation - Form 483, 2023-09-14
May, 2024 FDA 483 Willow Birch Pharma Inc - Form 483, 2024-05-03
April, 2022 FDA 483 Nephron SC Inc. - Form 483, 2022-04-20
July, 2022 FDA 483 Nephron Sterile Compounding Center, LLC - Form 483, 2022-04-20
March, 2022 FDA 483 Allied Analytical Laboratory Services - Form 483, 2022-03-02
July, 2022 EIR Aphena Pharma Solutions - Tennessee, LLC - EIR, 2022-07-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more